Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

In multiple myeloma patients, autologous stem cell transplants abrogate the difference of treating them with two or three drug combinations: Real world data from a single institution in a middle-income country.

Sofía Chávez Martínez, Lidia Alberto López, Olivia Lira Lara, Miguel Viveros Lugo, Michelle Lavoignet Cisneros, Mónica Salgado Cabrera, Miguel Gómez Cabrera, Guillermo Álvarez Silva, Max Robles Nasta, Juan Olivares-Gazca, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7604.

https://doi.org/10.1182/blood-2025-7604

Published: 2025

Journal Articles

The number of CD34 cells employed in autologous hematopoietic stem cell transplantation in persons with multiple sclerosis is unrelated to the neurological outcome of the procedure. experience in 1417 patients.

Michelle Lavoignet Cisneros, Olivia Lira Lara, Miguel Viveros Lugo, Sofía Chávez Martínez, Mónica Salgado Cabrera, Lidia Alberto López, Gabriela Flores Vargas, Juan Olivares-Gazca, Max Robles Nasta, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7617.

https://doi.org/10.1182/blood-2025-7617

Published: 2025

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia: Ambulatory or in-Hospital?

Guillermo José Ruiz-Argüelles, Olivia Lira-Lara, Max Robles-Nasta, Juan Carlos Olivares-Gazca, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, David Gomez-Almaguer, Oscar Gonzalez Llano, Yajaira Valentina Jimenez-Antolinez, Guillermo José Ruiz-Delgado

Blood (2024) 144 (Supplement 1): 7427.

https://doi.org/10.1182/blood-2024-199795

Published: 2024

Journal Articles

Early Morbimortality in Autologous Stem Cell Transplants Conducted on an Outpatient Basis in Persons with Autoimmune Disease: Experience in 1674 Patients

Guillermo José Ruiz-Argüelles, Olivia Lira-Lara, Max Robles-Nasta, Juan Carlos Olivares-Gazca, Montserrat Rivera-Álvarez, David Gomez-Almaguer, Andres Gomez-De Leon, Guillermo José Ruiz-Delgado

Blood (2024) 144 (Supplement 1): 7109.

https://doi.org/10.1182/blood-2024-199769

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

In multiple myeloma patients, autologous stem cell transplants abrogate the difference of treating them with two or three drug combinations: Real world data from a single institution in a middle-income country.

The number of CD34 cells employed in autologous hematopoietic stem cell transplantation in persons with multiple sclerosis is unrelated to the neurological outcome of the procedure. experience in 1417 patients.

Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia: Ambulatory or in-Hospital?

Early Morbimortality in Autologous Stem Cell Transplants Conducted on an Outpatient Basis in Persons with Autoimmune Disease: Experience in 1674 Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

In multiple myeloma patients, autologous stem cell transplants abrogate the difference of treating them with two or three drug combinations: Real world data from a single institution in a middle-income country.

The number of CD34 cells employed in autologous hematopoietic stem cell transplantation in persons with multiple sclerosis is unrelated to the neurological outcome of the procedure. experience in 1417 patients.

Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia: Ambulatory or in-Hospital?

Early Morbimortality in Autologous Stem Cell Transplants Conducted on an Outpatient Basis in Persons with Autoimmune Disease: Experience in 1674 Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only